Crossmark

Mass spectrometry-based lipidomics identifies select triacylglycerol species as differentially abundant in the bone marrow microenvironment of patients with multiple myeloma compared to monoclonal gammopathy of unknown significance

Crossref DOI link: https://doi.org/10.1007/s11306-025-02271-x

Published Online: 2025-06-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chawla, Yogesh

Anderson, Emilie I.

Jevremovic, Dragan

Kumar, Shaji K.

Hitosugi, Taro

Gonsalves, Wilson I.
Funding

Funding for this research was provided by:

National Cancer Institute (R01CA254961)

Marion Schwartz Foundation for Multiple Myeloma

National Cancer Institute,United States (U01CA271410)
License Information

Text and Data Mining valid from 2025-06-01

Version of Record valid from 2025-06-01
More Information

Article History

Received: 6 December 2024

Accepted: 18 May 2025

First Online: 1 June 2025

Declarations

:

: The study was conducted with approval of the Mayo Clinic Institutional Review Board and in accordance with the principles of the Declaration of Helsinki.

: These authors declare no competing financial interests.

Document is current

Any future updates will be listed below